Symmetry Investments’s STAAR Surgical STAA Stock Holding History

Symmetry Investments’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,000	Closed	-$924K	–	176
2025 Q4	$924K	Buy	+40,000	New	+$1.03M	0.08%	122

Other funds holding STAA

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIM

Anatole Investment Management Central, Hong Kong $590M AUM 751.98% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Symmetry Investments's STAA Position: Q1 2026 in Review

Symmetry Investments sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 40,000 shares — an estimated $924K sold.

Symmetry Investments first reported a position in STAA in Q4 2025 and held it in 1 quarter. The position peaked at $924K in Q4 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

Symmetry Investments reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
Symmetry Investments sold 40,000 STAAR Surgical shares in Q1 2026, an estimated $924K.
Symmetry Investments first reported a position in STAAR Surgical in Q4 2025 and held it in 1 quarter.
Symmetry Investments's STAAR Surgical position peaked at $924K in Q4 2025.
187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Symmetry Investments's 13F filing for Q1 2026, filed 15 May 2026.